Here are the 8-K filings from National Healthcare Properties, Inc. (NHP) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow NHP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHP filings page.
National Healthcare Properties, Inc. (NHP) reported third-quarter 2026 tenant revenue of $103.062 million, versus $86.026 million a year earlier, and net income attributable to common stockholders of $17.778 million, versus a $15.881 million loss. Diluted FFO per share fell 43.5% to $0.13; normalized FFO per share fell 29.6% to $0.19. SHOP same-store Cash NOI grew 13.6% year over year.
In the quarter, NHP acquired 22 SHOP communities with 1,381 units for $300 million; 2026 SHOP acquisitions completed or under definitive agreement totaled $664 million. It completed the sale of 30 OMFs for $198 million and repaid $119 million across two secured term loans. The remaining 56 OMFs, subject to a $219 million loan assumption, are expected to close in Q4 2026 for $331 million.
As of September 30, 2026, total debt outstanding, net of discounts and unamortized debt issuance costs, was $851.2 million; net leverage was 5.5x, versus 8.8x a year earlier. After redeeming all outstanding Series A and Series B preferred shares, NHP expects to save approximately $11 million in annual preferred dividends.
National Healthcare Properties, Inc. (NHP) automatically converted 44,275,000 issued and outstanding Class A common shares into common shares on a one-for-one basis on October 18, 2026, under the self-executing terms of its charter. Immediately after the conversion, 72,910,570 common shares were issued and outstanding; no Class A shares remained issued, outstanding, or authorized.
The total authorized share count remained 350,000,000, comprising 300,000,000 common shares and 50,000,000 preferred shares. Common shares began trading on the Nasdaq Global Market under NHP at 9:30 a.m. Eastern time on October 19, 2026, when Class A trading ceased. The conversion did not change former Class A holders’ economic interests; the class’s separate voting right on certain charter amendments no longer applies.
National Healthcare Properties, Inc. (NHP) said that certain termination rights of the purchaser ended September 25, 2026, under an agreement for certain subsidiaries to sell the company’s portfolio of 40 outpatient medical facilities to an unaffiliated third party for approximately $531 million. The amount is before transaction expenses, property operating prorations, capital expenditure and other adjustments.
The purchase and sale agreement is dated July 15, 2026, and the transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions specified in the agreement.
National Healthcare Properties, Inc. (NHP) reports that director Edward M. Weil, Jr. resigned from its board of directors, effective September 11, 2026. The company states that his decision to resign was not the result of any disagreement regarding its operations, policies, or practices.
National Healthcare Properties, Inc. (NHP) completed the first tranche of a previously announced sale of a portfolio of outpatient medical facilities. On September 10, 2026, the company, through subsidiaries of its operating partnership, closed on the sale of 30 properties out of an overall 86-facility portfolio to an unaffiliated buyer under a Purchase and Sale of Real Property Agreement dated May 4, 2026, as amended. The company received approximately $79 million in net cash proceeds at closing, before transaction expenses, property operating prorations and other adjustments. In connection with this transaction, it repaid approximately $119 million of outstanding secured indebtedness, including about $60 million of debt secured by other outpatient medical facilities that are not part of this portfolio. The company states that there are no material relationships between the seller entities and the buyer or their respective affiliates other than this sale.
National Healthcare Properties entered into a $1.2 billion amended and restated unsecured credit agreement with a $750 million revolving facility, $300 million term loan and $150 million delayed draw term loan, extended 2029–2030 maturities, an accordion of up to $1.0 billion and improved pricing, and used the recast to repay $332 million of Fannie Mae secured debt.
For Q2 2026, net loss attributable to common stockholders was $8.1 million, or $(0.13) per share, Nareit FFO was $0.19 per diluted share and Normalized FFO was $0.18 per diluted share, which decreased 18.2% year over year. Portfolio Same Store Cash NOI grew 6.8%, driven by the SHOP segment with 20.1% Same Store Cash NOI growth and 84.1% Same Store occupancy, while OMF Same Store Cash NOI decreased 0.4%.
Total debt was about $0.8 billion and Net Leverage improved to 4.9x from 9.2x a year earlier. The company completed or agreed to roughly $400 million of 2026 SHOP acquisitions, raised $531.3 million from its IPO of 44.3 million Class A shares, elected to redeem all 3,289,061 Series A and 2,850,427 Series B preferred shares at $25.32 and $25.47 per share including accrued dividends, and appointed experienced REIT executive Albert M. Campbell to its board and audit committee. Full-year 2026 guidance was updated, including higher expected SHOP Same Store Cash NOI growth of 15.0%–18.0%.
National Healthcare Properties, Inc. amended the executive employment agreement with its Chief Executive Officer and President, Michael Anderson. The amendment extends the agreement’s term from September 27, 2027 to September 27, 2030. After that date, the agreement will automatically renew for additional one-year periods unless either party gives written notice at least 90 days before the applicable term date. All other provisions, including compensatory terms, remain unchanged from those described in the company’s March 31, 2026 proxy statement.
National Healthcare Properties, Inc. (NHP) disclosed that MacKenzie Capital Management launched an unsolicited mini-tender offer to buy up to 150,000 common shares, about 0.2% of outstanding stock, at $7.27 per share. This price is approximately 47.2% below the $13.78 last reported sale price of NHP’s Class A common stock on Nasdaq as of June 15, 2026.
After consulting outside advisors, NHP’s board decided not to make a recommendation and to remain neutral on whether stockholders should tender. The company’s letter notes that tendering holders would give up rights to future distributions after March 31, 2026 and that the MacKenzie offer price will be reduced by any cash distributions made after that date. It also highlights that NHP insiders do not intend to tender and references SEC cautions about mini-tender offers.
National Healthcare Properties, Inc. launched concurrent cash tender offers of up to $100 million in aggregate to repurchase its 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred stock.
Both series are offered at $22.50 per share, less any applicable withholding taxes and without interest. The offers commence on May 18, 2026 and are intended to expire at 5:00 p.m. New York City time on June 16, 2026, unless extended or terminated. The company plans to fund the repurchases with available cash.
Series A shares have higher purchase priority than Series B, and within each offer, holders of fewer than 100 shares who tender all their holdings receive “odd lot” priority. If tenders exceed the $100 million cap, Series B tenders may be prorated. The offers are not contingent on financing or any minimum number of shares, but remain subject to other conditions detailed in a forthcoming Offer to Purchase and related Schedule TO materials.
National Healthcare Properties, Inc. entered into a definitive purchase and sale agreement to sell a portfolio of 86 outpatient medical facilities for approximately $528 million, including about $278 million of secured debt to be defeased or assumed by the purchaser.
The agreement with an unaffiliated third party includes customary representations, covenants and post-closing obligations. The transaction is expected to close in the third or fourth quarter of 2026, subject to the purchaser’s due diligence, lender approval of loan assumptions and other customary closing conditions. This Form 8‑K/A amends the prior report solely to correct a typographical error.
National Healthcare Properties, Inc. reported results of its 2026 annual stockholder meeting. Stockholders present in person or by proxy held 14,327,574 common shares out of 28,412,183 entitled to vote, representing approximately 50.42% of voting power, which established a quorum.
All six director nominees — Leslie D. Michelson, Scott W. Humphrey, Elizabeth K. Tuppeny, B.J. Penn, Edward M. Weil, Jr. and Michael Anderson — were elected to serve until the 2027 annual meeting. Stockholders also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.
In advisory votes, stockholders approved the resolution on the compensation of named executive officers and supported holding this advisory vote every year. Based on these results, the board determined that say-on-pay advisory votes will be held annually until at least the 2032 annual meeting.
National Healthcare Properties, Inc. reported first quarter 2026 results showing strong operating improvement but a GAAP net loss. Net loss attributable to common stockholders was $7.6 million, or $0.27 per share, while Nareit FFO reached $0.31 per diluted share and Normalized FFO was $0.26 per diluted share.
Same Store Cash NOI grew 12.0% year-over-year, led by 24.0% growth in the senior housing operating (SHOP) segment, where occupancy rose to 83.8% and margins expanded. The outpatient medical facility (OMF) segment delivered 5.5% Same Store Cash NOI growth with 94.0% ending occupancy.
The company is actively reshaping its portfolio, agreeing to acquire multiple senior living communities totaling over $125 million and to sell 86 outpatient medical facilities for about $528.2 million. Net leverage improved to 8.6x, and a subsequent IPO raised $531.3 million, with $186.0 million used to pay down the revolving credit facility.
National Healthcare Properties, Inc. agreed to sell a portfolio of 86 outpatient medical facilities under a definitive purchase and sale agreement with an affiliated third party. The portfolio is valued at approximately $528 million, including about $278 million of secured debt to be defeased or assumed by the buyer.
The agreement includes customary representations, warranties, covenants and post-closing obligations. Closing is expected in the third or fourth quarter of 2026, subject to the purchaser’s due diligence, lender approval for loan assumptions, and other customary closing conditions specified in the agreement.
National Healthcare Properties, Inc. closed a registered underwritten public offering of 38,500,000 shares of Class A common stock, followed by the underwriters’ exercise of an option for 5,775,000 additional shares to cover overallotments. The option shares closing completed on April 28, 2026.
In connection with the offering, the company entered into an Amended and Restated Agreement of Limited Partnership for its operating partnership. This reset the OP Unit exchange factor to 1.0, eliminated Class B Units, removed a crystallized special interest, and created new LTIP Unit classes.
The board also approved listing-related equity awards under the 2025 Omnibus Incentive Compensation Plan. Employees, including named executive officers, received an aggregate 995,994 shares and LTIP Units vesting in 25% annual increments from April 30, 2027. The CEO, CFO and CAO were granted 348,665, 149,428 and 25,000 LTIP Units, respectively, and each director was authorized 12,500 restricted shares and/or LTIP Units.
National Healthcare Properties, Inc. entered into an Underwriting Agreement and closed a registered underwritten public offering of 38,500,000 shares of its Class A common stock under an effective Form S-11 registration statement. On April 24, 2026, the underwriters exercised their option to purchase an additional 5,775,000 shares to cover overallotments, with that closing expected on April 28, 2026. The agreement with Wells Fargo Securities, Morgan Stanley, BMO Capital Markets and other underwriters includes customary representations, covenants, indemnification and termination provisions.